Clinical Trial Update: Phase III Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis [Phase 3]

View source ↗

Summary

Phase III clinical trial update for VC005 Tablets in adults with moderate to severe atopic dermatitis; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• VC005 Tablets

Snippet

Sponsor: Jiangsu vcare pharmaceutical technology co., LTD | Conditions: Moderate to Severe Atopic Dermatitis | Phase 3 | Status: RECRUITING